A Week in the Market: OPEC+ Meeting and US Labour Market (1 – 5 August) – R Blog
[ad_1] As usual, the beginning of the month will bring in a flow of statistics from all over the world and form some understanding of what is going on in…
Amgen (AMGN) To Fight Internal Revenue Service (IRS) After $10.7 Billion Tax Bill
[ad_1] Amgen Inc AMGN will fight Internal Revenue Service over the company’s international tax strategy and $10.7 billion in back taxes and penalties, Wall Street Journal reported. The IRS agency…
Why Kazia Therapeutics (KZIA) Shares Are Plunging Today
[ad_1] Kazia Therapeutics Limited KZIA said GBM AGILE, a pivotal study for paxalisib in newly diagnosed glioblastoma, did not meet pre-defined criteria for continuing to a second stage. Patients enrolled in…
Market Insights Podcast (Episode 359)
[ad_1] Based in London, Craig Erlam joined OANDA in 2015 as a market analyst. With many years of experience as a financial market analyst and trader, he focuses on both…
Why Celyad Oncology (CYAD) Shares Are Surging Today
[ad_1] The FDA has lifted the clinical hold on Celyad Oncology SA’s CYAD CYAD-101-002 (KEYNOTE-B79) Phase 1b trial after the company made changes to the eligibility criteria for the trial. “We remain…